Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T de Witte

Showing results (111-120 of 264) with videos related to

Pageof 27
Sort By:
Leukemia & Lymphoma|May 9, 2001
Relationship of the CD22 immunotoxin dose and the tumour establishment in a SCID mice modelP J Van Horssen, F W Preijers, Y V Van Oosterhout, et al.
Leukemia|August 23, 2001
Induction of graft-versus-leukemia to prevent relapse after partially lymphocyte-depleted allogeneic bone marrow transplantation by pre-emptive donor leukocyte infusionsN Schaap, A Schattenberg, B Bär, et al.
Leukemia|March 1, 1994
Toxicity of idarubicin and doxorubicin towards normal and leukemic human bone marrow progenitors in relation to their proliferative stateH Minderman, P Linssen, N van der Lely, et al.
Leukemia|January 15, 2010
The NDE1 gene is disrupted by the inv(16) in 90% of cases with CBFB-MYH11-positive acute myeloid leukemiaB A Van der Reijden, M Massop, A Simons, et al.
Cytometry|November 28, 2002
Single-cell image analysis to assess ABC-transporter-mediated efflux in highly purified hematopoietic progenitorsH G P Raaijmakers, G Van Den Bosch, J Boezeman, et al.
British Journal of Haematology|February 1, 1989
Cytotoxic potential of anti-CD7 immunotoxin (WT1-ricin A) to purge ex vivo malignant T cells in bone marrowF W Preijers, T De Witte, J M Wessels, et al.
Bone Marrow Transplantation|June 18, 1999
Counterflow centrifugation allows addition of appropriate numbers of T cells to allogeneic marrow and blood stem cell grafts to prevent severe GVHD without substantial loss of mature and immature progenitor cellsF W Preijers, P B van Hennik, A Schattenberg, et al.
Bone Marrow Transplantation|July 1, 1992
Influence of the conditioning regimen on erythrocyte chimerism, graft-versus-host disease and relapse after allogeneic transplantation with lymphocyte depleted marrowB M Bär, A Schattenberg, A J De Man, et al.
European Radiology|October 23, 2012
Miss rate of colorectal cancer at CT colonography in average-risk symptomatic patientsP C G Simons, L N Van Steenbergen, M T De Witte, et al.
Scandinavian Journal of Immunology|May 1, 1988
Different susceptibilities of normal T cells and T cell lines to immunotoxinsF W Preijers, W J Tax, J M Wessels, et al.
Pageof 27

Showing results (111-120 of 264) with videos related to

Sort By:
Pageof 27
Leukemia & Lymphoma|May 9, 2001
Relationship of the CD22 immunotoxin dose and the tumour establishment in a SCID mice modelP J Van Horssen, F W Preijers, Y V Van Oosterhout, et al.
Leukemia|August 23, 2001
Induction of graft-versus-leukemia to prevent relapse after partially lymphocyte-depleted allogeneic bone marrow transplantation by pre-emptive donor leukocyte infusionsN Schaap, A Schattenberg, B Bär, et al.
Leukemia|March 1, 1994
Toxicity of idarubicin and doxorubicin towards normal and leukemic human bone marrow progenitors in relation to their proliferative stateH Minderman, P Linssen, N van der Lely, et al.
Leukemia|January 15, 2010
The NDE1 gene is disrupted by the inv(16) in 90% of cases with CBFB-MYH11-positive acute myeloid leukemiaB A Van der Reijden, M Massop, A Simons, et al.
Cytometry|November 28, 2002
Single-cell image analysis to assess ABC-transporter-mediated efflux in highly purified hematopoietic progenitorsH G P Raaijmakers, G Van Den Bosch, J Boezeman, et al.
British Journal of Haematology|February 1, 1989
Cytotoxic potential of anti-CD7 immunotoxin (WT1-ricin A) to purge ex vivo malignant T cells in bone marrowF W Preijers, T De Witte, J M Wessels, et al.
Bone Marrow Transplantation|June 18, 1999
Counterflow centrifugation allows addition of appropriate numbers of T cells to allogeneic marrow and blood stem cell grafts to prevent severe GVHD without substantial loss of mature and immature progenitor cellsF W Preijers, P B van Hennik, A Schattenberg, et al.
Bone Marrow Transplantation|July 1, 1992
Influence of the conditioning regimen on erythrocyte chimerism, graft-versus-host disease and relapse after allogeneic transplantation with lymphocyte depleted marrowB M Bär, A Schattenberg, A J De Man, et al.
European Radiology|October 23, 2012
Miss rate of colorectal cancer at CT colonography in average-risk symptomatic patientsP C G Simons, L N Van Steenbergen, M T De Witte, et al.
Scandinavian Journal of Immunology|May 1, 1988
Different susceptibilities of normal T cells and T cell lines to immunotoxinsF W Preijers, W J Tax, J M Wessels, et al.
Pageof 27